Buy AOD 9604: Modified GH Fragment 177-191 Lipolytic Action

DER

Reviewed by Dr. Elena Rostova

Molecular Pharmacology & Analytical Chemistry Reviewer

Expert in peptide receptor kinetics, cellular signaling pathways, and peptide stability.

⚠️ Laboratory Research Notice

All peptide compounds discussed in this guide are strictly intended for in vitro cellular research, analytical laboratory testing, and chemical evaluation. They are not approved for human or animal consumption, diagnostic use, or therapeutic applications.

AOD 9604 (Advanced Obesity Drug 9604) is a synthetic 16-amino-acid peptide derived from the C-terminal lipolytic domain of human Growth Hormone (hGH amino acids 177–191), stabilized with an additional tyrosine residue at the N-terminus and an internal disulfide bridge.

When biomedical researchers buy AOD 9604, its primary value lies in its ability to stimulate lipolysis and inhibit lipogenesis in cellular adipose models without altering systemic insulin sensitivity or stimulating IGF-1 secretion.

Biochemical Mechanism: Pure Lipolysis Without GH Side Effects

Full-length human growth hormone (191 amino acids) exerts complex pleiotropic effects, stimulating cell growth, collagen synthesis, and protein accretion, but also inducing insulin resistance and elevated blood glucose.

AOD 9604 isolates the lipolytic domain:
– Beta-3 Adrenergic Receptor Activation: AOD 9604 stimulates beta-3 adrenergic receptors on adipocytes, upregulating hormone-sensitive lipase (HSL) and accelerating triglyceride breakdown into free fatty acids and glycerol.
– Inhibition of Lipogenesis: It suppresses acetyl-CoA carboxylase, reducing the conversion of glucose into stored fat.
– Zero Impact on Glycemia & IGF-1: Unlike full-length GH, AOD 9604 does not bind to the hGH receptor, producing zero elevation of IGF-1 and zero disruption of glucose tolerance in cellular models.

🧭 Metabolic Pathway: Buy Aod 9604

Step 1

Adipocyte Receptor Binding

AOD 9604 engages beta-3 adrenergic pathways on fat cell membranes.

↓

Step 2

cAMP & PKA Activation

Stimulates protein kinase A to phosphorylate hormone-sensitive lipase.

↓

Step 3

Triglyceride Hydrolysis

Stored triglycerides are cleaved into free fatty acids and glycerol.

↓

Step 4

Lipogenesis Blockade

Suppresses lipogenic enzymes to prevent new intracellular fat storage.

Chemical Characteristics of AOD 9604

Analytical profile of research-grade AOD 9604:

📊 Analytical Specifications: Buy Aod 9604

Specification	Analytical Detail
Amino Acid Sequence	Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (with Cys7-Cys14 disulfide bridge)
Molecular Formula	C78H123N23O23S2
Molecular Weight	1815.1 g/mol
Disulfide Bridge	Intact Cys-Cys bond essential for biological activity
Recommended Purity	≥ 98.5% by RP-HPLC

Handling and Disulfide Bridge Preservation

Because AOD 9604 relies on an internal disulfide bond between cysteine residues, avoid exposing reconstituted solutions to reducing agents (such as DTT or beta-mercaptoethanol). Reconstitute with sterile bacteriostatic water and store at 2°C to 8°C.

Frequently Asked Questions

❓ How does AOD 9604 differ from Frag 176-191?

AOD 9604 is an analogue of Fragment 176-191 with an added N-terminal tyrosine residue, designed to enhance stability and lipolytic potency.

❓ Does AOD 9604 affect cartilage cells?

Recent research has explored AOD 9604 in chondrocyte and cartilage regeneration models, showing promising proteoglycan synthesis pathways.

❓ Where can I learn more about peptide vendors?

Review our Best Peptide Vendors Ranked.